Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cannabinoid modulation of neuroinflammatory disorders.
Toll-like receptor-9 in Spanish multiple sclerosis patients: an association with the gender.
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal.
Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression.
A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis.
Errata-corrige. Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis.
T cell-activation in neuromyelitis optica lesions plays a role in their formation.
Interferon beta-associated recurrence of painful trigeminal neuropathy attributed to a multiple sclerosis plaque.
MK2 and Fas Receptor Contribute to the Severity of CNS Demyelination.
Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.
NMO spectrum disorders: how wide is the spectrum?
Systematic framework to evaluate the status of physical activity research for persons with multiple sclerosis.
Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis.
[NLRP3 inflammasome and multiple sclerosis/EAE].
Evaluation of the Degradation of the Selected Projectile, Commissural and Association White Matter Tracts Within Normal Appearing White Matter in Patients with Multiple Sclerosis Using Diffusion Tensor MR Imaging - a Preliminary Study.
Editorial: Plasticity in Multiple Sclerosis: From Molecular to System Level, from Adaptation to Maladaptation.
Amantadine: Multiple Sclerosis-Related Fatigue.
Microglia: Multitasking Specialists of the Brain.
Oral Administration of Lactococcus lactis Expressing Synthetic Genes of Myelin Antigens in Decreasing Experimental Autoimmune Encephalomyelitis in Rats.
Characterization of dose-response for count data using a generalized MCP-Mod approach in an adaptive dose-ranging trial.
Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis.
C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica.
NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathy.
Combining genetic mapping with genome-wide expression in experimental autoimmune encephalomyelitis highlights a gene network enriched for T cell functions and candidate genes regulating autoimmunity.
Personalization of multiple sclerosis treatments: using the chelation therapy approach.
Pages
« first
‹ previous
…
524
525
526
527
528
529
530
531
532
…
next ›
last »